Releases Saturday 1 November 2003
No 7422 Volume 327

Please remember to credit the BMJ as source when publicising an
article and to tell your readers that they can read its full text on the
journal's web site (http://bmj.com).

If your story is posted on a website please include a link back to
the source BMJ article (URL's are given under titles).


(1) HOW CAN WE SECURE THE FUTURE OF
MEDICAL RESEARCH?

(2) ONE IN TEN HOSPITAL LIFT RIDES BREACH
PATIENT PRIVACY

(3) ADVANCE DIRECTIVES OPEN TO DIFFERENT
INTERPRETATIONS



(1) HOW CAN WE SECURE THE FUTURE OF
MEDICAL RESEARCH?

(Descriptive survey of non-commercial randomised
controlled trials in the United Kingdom)
http://bmj.com/cgi/content/full/327/7422/1017

(Resuscitating clinical research in the United Kingdom)
http://bmj.com/cgi/content/full/327/7422/1041

(Editorials)
http://bmj.com/cgi/content/full/327/7422/1001

Clinical research in Britain is in decline. This week's BMJ
reveals that the number of non-commercial trials has
fallen in recent years, while a summary of a new report
from the Academy of Medical Sciences sets out what is
needed to revitalise clinical research.

Researchers identified 1,464 randomised controlled trials
supported by the main non-commercial sources of
funding in the UK (Medical Research Council, NHS,
and medical research charities) between 1980 and 2002.

They found that the number of trials declined without any
associated increase in the sample sizes of these studies.
Of 615 trials funded by the NHS or Department of
Health during this time, 514 (83.6%) were funded
through programmes that were discontinued.

Support also seems to be declining from the Medical
Research Council and the medical research charities, say
the authors, and they call for a coherent strategy to
ensure support for trials that address issues of no interest
to industry but are of great importance to patients and
practitioners.

Failure to energise clinical research will have serious
implications for the future of health care, patients, and
those trying to develop new medicines, warn the
Academy of Medical Sciences in a new report
"Strengthening clinical research."

They highlight the challenges facing research in the NHS
and set out recommendations for overcoming these
obstacles. These include establishing a national network
for clinical research, better career and reward structures
for researchers, and increased funding from all sources.

Contact:

Emma Dickinson, BMA Press Office, London, UK
Email: edickinson@bma.org.uk

(2) ONE IN TEN HOSPITAL LIFT RIDES BREACH
PATIENT PRIVACY

(Privacy of patients' information in hospital lifts:
observational study)
http://bmj.com/cgi/content/full/327/7422/1024

More than one in ten hospital lift rides breach patient
privacy, according to a study in this week's BMJ.

Medical students at St Michael's Hospital in Toronto
recorded the date, time, duration, and location of every
journey they took in a public lift at the hospital during
regular hours for two weeks in November 2002.

They recorded all compromises of patients'
confidentiality by hospital staff and any reactions by
witnesses to these comments.

Hospital staff made 18 comments deemed to
compromise a patients' confidentiality on 13 out of 113
lift journeys (observers overheard multiple comments on
some journeys). Reactions attempting to minimise
breaches by medical students not involved in the study
happened on two occasions.

Breaches of a patient's confidentiality compromise ethical
health care and undermine patients' confidence in
caregivers, say the authors. Clarification of what
constitutes a breach in patient confidentiality is needed
and healthcare institutions must provide effective training
to minimise these breaches, they conclude.

Contact:

John Bohnen, Associate Professor, Departments of
Surgery and Health Policy, St Michael's Hospital,
University of Toronto, Canada
Email: macisaact@smh.toronto.on.ca

(3) ADVANCE DIRECTIVES OPEN TO DIFFERENT
INTERPRETATIONS

(Adherence to advance directives in critical care decision
making: vignette study)
http://bmj.com/cgi/content/full/327/7422/1011

Health professionals come to different conclusions about
the "right thing to do" when applying the terms of an
advance directive to a clinical scenario, finds a study in
this week's BMJ.

Advance directives are written statements about future
treatment preferences made when a patient is in sound
mind.

Researchers conducted interviews and focus groups with
general practitioners, hospital specialists, and nurses.
They were given a hypothetical advance directive and
asked what they believed was the "right thing to do" in a
particular critical care scenario involving a mildly
demented woman with suspected pneumonia.

Health professionals came to different conclusions about
the "right thing to do." Those who favoured treatment
thought the directive did not apply, or saw adherence to
the directive as not being in the patient's best interests.
Those who opposed treatment centred on respect for
autonomy as an ethical principle.

Some of this variability was related to the ambiguity of
the directive's terminology whereas some was related to
the willingness of health professionals to make subjective
value judgements concerning quality of life.

Advance directives will not lessen the responsibility of
health professionals to weigh up a range of conflicting
considerations, say the authors. Medical education
should seek to develop students' empathetic skills and
scenarios such as this could be used for this purpose,
they conclude.

Contact:

Trevor Thompson, Clinical Lecturer, Division of Primary
Health Care, University of Bristol, UK
Email: trevor.thompson@bristol.ac.uk /
trevorthompson@btinternet.com


FOR ACCREDITED JOURNALISTS

Embargoed press releases and articles are available from:

Public Affairs Division
BMA House
Tavistock Square
London WC1H 9JR
(contact: pressoffice@bma.org.uk)

and from:

the EurekAlert website, run by the American Association for the
Advancement of Science
(http://www.eurekalert.org)